WO2022270598A1 - 動物細胞培養用組成物の製造方法、それにより得られる動物細胞培養用組成物及びそれを用いた動物細胞の培養方法 - Google Patents
動物細胞培養用組成物の製造方法、それにより得られる動物細胞培養用組成物及びそれを用いた動物細胞の培養方法 Download PDFInfo
- Publication number
- WO2022270598A1 WO2022270598A1 PCT/JP2022/025179 JP2022025179W WO2022270598A1 WO 2022270598 A1 WO2022270598 A1 WO 2022270598A1 JP 2022025179 W JP2022025179 W JP 2022025179W WO 2022270598 A1 WO2022270598 A1 WO 2022270598A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- algae
- cell culture
- animal cell
- composition
- animal cells
- Prior art date
Links
- 210000004102 animal cell Anatomy 0.000 title claims abstract description 131
- 238000000034 method Methods 0.000 title claims abstract description 70
- 239000000203 mixture Substances 0.000 title claims abstract description 50
- 238000012258 culturing Methods 0.000 title claims abstract description 44
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 22
- 241000195493 Cryptophyta Species 0.000 claims abstract description 120
- 239000000284 extract Substances 0.000 claims abstract description 82
- 239000011973 solid acid Substances 0.000 claims abstract description 46
- 239000007788 liquid Substances 0.000 claims abstract description 44
- 239000002699 waste material Substances 0.000 claims abstract description 36
- 239000003054 catalyst Substances 0.000 claims abstract description 34
- 238000010438 heat treatment Methods 0.000 claims abstract description 17
- 238000004064 recycling Methods 0.000 claims abstract description 7
- 238000004113 cell culture Methods 0.000 claims description 61
- 239000002609 medium Substances 0.000 claims description 54
- 239000006143 cell culture medium Substances 0.000 claims description 31
- 210000002966 serum Anatomy 0.000 claims description 29
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 26
- 239000008103 glucose Substances 0.000 claims description 26
- 229940024606 amino acid Drugs 0.000 claims description 24
- 235000001014 amino acid Nutrition 0.000 claims description 24
- 150000001413 amino acids Chemical class 0.000 claims description 24
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 18
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 18
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 18
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 18
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 18
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 18
- 229940088594 vitamin Drugs 0.000 claims description 18
- 229930003231 vitamin Natural products 0.000 claims description 18
- 235000013343 vitamin Nutrition 0.000 claims description 18
- 239000011782 vitamin Substances 0.000 claims description 18
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 17
- 238000002156 mixing Methods 0.000 claims description 15
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 11
- 241000195649 Chlorella <Chlorellales> Species 0.000 claims description 10
- 229930182816 L-glutamine Natural products 0.000 claims description 10
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 claims description 10
- 239000004471 Glycine Substances 0.000 claims description 9
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 claims description 9
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims description 9
- 229930064664 L-arginine Natural products 0.000 claims description 9
- 235000014852 L-arginine Nutrition 0.000 claims description 9
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims description 9
- 239000004158 L-cystine Substances 0.000 claims description 9
- 235000019393 L-cystine Nutrition 0.000 claims description 9
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 9
- 229930182844 L-isoleucine Natural products 0.000 claims description 9
- 239000004395 L-leucine Substances 0.000 claims description 9
- 235000019454 L-leucine Nutrition 0.000 claims description 9
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 9
- 229930195722 L-methionine Natural products 0.000 claims description 9
- 239000004473 Threonine Substances 0.000 claims description 9
- 229960003067 cystine Drugs 0.000 claims description 9
- 229960002885 histidine Drugs 0.000 claims description 9
- 229960000310 isoleucine Drugs 0.000 claims description 9
- 229960003136 leucine Drugs 0.000 claims description 9
- 229960004452 methionine Drugs 0.000 claims description 9
- 229960001153 serine Drugs 0.000 claims description 9
- 229960002898 threonine Drugs 0.000 claims description 9
- 229960004441 tyrosine Drugs 0.000 claims description 9
- 229960004295 valine Drugs 0.000 claims description 9
- 229960002449 glycine Drugs 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 229920005989 resin Polymers 0.000 claims description 6
- 239000011347 resin Substances 0.000 claims description 6
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 claims description 6
- KXGFMDJXCMQABM-UHFFFAOYSA-N 2-methoxy-6-methylphenol Chemical compound [CH]OC1=CC=CC([CH])=C1O KXGFMDJXCMQABM-UHFFFAOYSA-N 0.000 claims description 5
- 229910017053 inorganic salt Inorganic materials 0.000 claims description 5
- 229920001568 phenolic resin Polymers 0.000 claims description 5
- 239000005011 phenolic resin Substances 0.000 claims description 5
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 3
- 239000003377 acid catalyst Substances 0.000 claims 1
- 239000011949 solid catalyst Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 48
- 235000015097 nutrients Nutrition 0.000 description 26
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 22
- 241000283690 Bos taurus Species 0.000 description 19
- 239000013505 freshwater Substances 0.000 description 17
- 210000003098 myoblast Anatomy 0.000 description 15
- 238000000605 extraction Methods 0.000 description 12
- 229910052500 inorganic mineral Inorganic materials 0.000 description 11
- 235000010755 mineral Nutrition 0.000 description 11
- 239000011707 mineral Substances 0.000 description 11
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 10
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 10
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 10
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 10
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 9
- 239000012091 fetal bovine serum Substances 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 7
- 230000007613 environmental effect Effects 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 6
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 239000000654 additive Substances 0.000 description 6
- 230000000996 additive effect Effects 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 6
- 235000014633 carbohydrates Nutrition 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 235000013372 meat Nutrition 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 5
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 5
- 235000019743 Choline chloride Nutrition 0.000 description 5
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 5
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 5
- 239000012888 bovine serum Substances 0.000 description 5
- 230000004663 cell proliferation Effects 0.000 description 5
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 5
- 229960003178 choline chloride Drugs 0.000 description 5
- 230000002950 deficient Effects 0.000 description 5
- 229960000304 folic acid Drugs 0.000 description 5
- 235000019152 folic acid Nutrition 0.000 description 5
- 239000011724 folic acid Substances 0.000 description 5
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 5
- 210000004962 mammalian cell Anatomy 0.000 description 5
- 229960003966 nicotinamide Drugs 0.000 description 5
- 239000011570 nicotinamide Substances 0.000 description 5
- 235000005152 nicotinamide Nutrition 0.000 description 5
- 229940055726 pantothenic acid Drugs 0.000 description 5
- 235000019161 pantothenic acid Nutrition 0.000 description 5
- 239000011713 pantothenic acid Substances 0.000 description 5
- 229960005190 phenylalanine Drugs 0.000 description 5
- 239000011677 pyridoxine Substances 0.000 description 5
- 235000008160 pyridoxine Nutrition 0.000 description 5
- 229960002477 riboflavin Drugs 0.000 description 5
- 239000002151 riboflavin Substances 0.000 description 5
- 235000019192 riboflavin Nutrition 0.000 description 5
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000011721 thiamine Substances 0.000 description 5
- 235000019157 thiamine Nutrition 0.000 description 5
- 229940011671 vitamin b6 Drugs 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 241000282414 Homo sapiens Species 0.000 description 4
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 4
- 238000010306 acid treatment Methods 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 238000012136 culture method Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 230000000153 supplemental effect Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000272517 Anseriformes Species 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- 240000009108 Chlorella vulgaris Species 0.000 description 3
- 241000180279 Chlorococcum Species 0.000 description 3
- 241000566265 Chlorococcum littorale Species 0.000 description 3
- 241000195628 Chlorophyta Species 0.000 description 3
- 241000192700 Cyanobacteria Species 0.000 description 3
- 241000283073 Equus caballus Species 0.000 description 3
- 229910000608 Fe(NO3)3.9H2O Inorganic materials 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 3
- 235000019766 L-Lysine Nutrition 0.000 description 3
- 241000270322 Lepidosauria Species 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 3
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 235000013330 chicken meat Nutrition 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 239000005431 greenhouse gas Substances 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019799 monosodium phosphate Nutrition 0.000 description 3
- 210000000663 muscle cell Anatomy 0.000 description 3
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 3
- 230000029553 photosynthesis Effects 0.000 description 3
- 238000010672 photosynthesis Methods 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 229940076788 pyruvate Drugs 0.000 description 3
- 239000012679 serum free medium Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 229910000162 sodium phosphate Inorganic materials 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 3
- 229960004799 tryptophan Drugs 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000238421 Arthropoda Species 0.000 description 2
- 240000002900 Arthrospira platensis Species 0.000 description 2
- 235000016425 Arthrospira platensis Nutrition 0.000 description 2
- 241000258957 Asteroidea Species 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- 241000238366 Cephalopoda Species 0.000 description 2
- 241000195585 Chlamydomonas Species 0.000 description 2
- 235000007089 Chlorella vulgaris Nutrition 0.000 description 2
- 241000238424 Crustacea Species 0.000 description 2
- 241000206584 Cyanidium caldarium Species 0.000 description 2
- 241000238557 Decapoda Species 0.000 description 2
- 241000258955 Echinodermata Species 0.000 description 2
- 241000257465 Echinoidea Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 241000251511 Holothuroidea Species 0.000 description 2
- 241000237852 Mollusca Species 0.000 description 2
- 241000238413 Octopus Species 0.000 description 2
- 241000286209 Phasianidae Species 0.000 description 2
- 239000012980 RPMI-1640 medium Substances 0.000 description 2
- 241000206572 Rhodophyta Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 241000192707 Synechococcus Species 0.000 description 2
- 241000251555 Tunicata Species 0.000 description 2
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 229960000074 biopharmaceutical Drugs 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 229930002868 chlorophyll a Natural products 0.000 description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 238000003912 environmental pollution Methods 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 239000003337 fertilizer Substances 0.000 description 2
- 239000006451 grace's insect medium Substances 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000001000 micrograph Methods 0.000 description 2
- 239000007758 minimum essential medium Substances 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 238000009304 pastoral farming Methods 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 229940107700 pyruvic acid Drugs 0.000 description 2
- 238000011158 quantitative evaluation Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000015170 shellfish Nutrition 0.000 description 2
- 238000006277 sulfonation reaction Methods 0.000 description 2
- NNMALANKTSRILL-LXENMSTPSA-N 3-[(2z,5e)-2-[[3-(2-carboxyethyl)-5-[(z)-[(3e,4r)-3-ethylidene-4-methyl-5-oxopyrrolidin-2-ylidene]methyl]-4-methyl-1h-pyrrol-2-yl]methylidene]-5-[(4-ethyl-3-methyl-5-oxopyrrol-2-yl)methylidene]-4-methylpyrrol-3-yl]propanoic acid Chemical compound O=C1C(CC)=C(C)C(\C=C\2C(=C(CCC(O)=O)C(=C/C3=C(C(C)=C(\C=C/4\C(\[C@@H](C)C(=O)N\4)=C\C)N3)CCC(O)=O)/N/2)C)=N1 NNMALANKTSRILL-LXENMSTPSA-N 0.000 description 1
- PMYDPQQPEAYXKD-UHFFFAOYSA-N 3-hydroxy-n-naphthalen-2-ylnaphthalene-2-carboxamide Chemical compound C1=CC=CC2=CC(NC(=O)C3=CC4=CC=CC=C4C=C3O)=CC=C21 PMYDPQQPEAYXKD-UHFFFAOYSA-N 0.000 description 1
- ZYUVGYBAPZYKSA-UHFFFAOYSA-N 5-(3-hydroxybutan-2-yl)-4-methylbenzene-1,3-diol Chemical compound CC(O)C(C)C1=CC(O)=CC(O)=C1C ZYUVGYBAPZYKSA-UHFFFAOYSA-N 0.000 description 1
- 241000007910 Acaryochloris marina Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 241000269350 Anura Species 0.000 description 1
- 241001495180 Arthrospira Species 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000269333 Caudata Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 241000196240 Characeae Species 0.000 description 1
- 241000195597 Chlamydomonas reinhardtii Species 0.000 description 1
- 244000249214 Chlorella pyrenoidosa Species 0.000 description 1
- 235000007091 Chlorella pyrenoidosa Nutrition 0.000 description 1
- 241000832151 Chlorella regularis Species 0.000 description 1
- 241000195651 Chlorella sp. Species 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 244000136995 Clinopodium vulgare Species 0.000 description 1
- 235000005956 Cosmos caudatus Nutrition 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 241000270722 Crocodylidae Species 0.000 description 1
- 241000252233 Cyprinus carpio Species 0.000 description 1
- 241000195633 Dunaliella salina Species 0.000 description 1
- 241000195619 Euglena gracilis Species 0.000 description 1
- 241001223004 Euglenaformis proxima Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241001646655 Galdieria partita Species 0.000 description 1
- 241000196171 Hydrodictyon reticulatum Species 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 229920000557 Nafion® Polymers 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000196150 Pediastrum duplex Species 0.000 description 1
- 241000195648 Pseudochlorella pringsheimii Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000269622 Salamandridae Species 0.000 description 1
- 241001466077 Salina Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 241000592344 Spermatophyta Species 0.000 description 1
- 241000530636 Spirulina subsalsa Species 0.000 description 1
- 241001148696 Stichococcus Species 0.000 description 1
- 241000192560 Synechococcus sp. Species 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 241000264606 Tetradesmus dimorphus Species 0.000 description 1
- 241001441724 Tetraodontidae Species 0.000 description 1
- 102000004338 Transferrin Human genes 0.000 description 1
- 108090000901 Transferrin Proteins 0.000 description 1
- 241000736687 Trebouxia Species 0.000 description 1
- 241001482311 Trionychidae Species 0.000 description 1
- 241000196252 Ulva Species 0.000 description 1
- 241000282458 Ursus sp. Species 0.000 description 1
- 241000195615 Volvox Species 0.000 description 1
- 241000195614 Volvox carteri Species 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940125644 antibody drug Drugs 0.000 description 1
- 229940011019 arthrospira platensis Drugs 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 210000004903 cardiac system Anatomy 0.000 description 1
- 238000012832 cell culture technique Methods 0.000 description 1
- 238000003570 cell viability assay Methods 0.000 description 1
- 238000013043 cell viability test Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
- 229930002869 chlorophyll b Natural products 0.000 description 1
- NSMUHPMZFPKNMZ-VBYMZDBQSA-M chlorophyll b Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C=O)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 NSMUHPMZFPKNMZ-VBYMZDBQSA-M 0.000 description 1
- 229930002863 chlorophyll d Natural products 0.000 description 1
- QXWRYZIMSXOOPY-SKHCYZARSA-M chlorophyll d Chemical compound C1([C@H](C2=O)C(=O)OC)=C(N3[Mg]N45)C2=C(C)\C3=C\C(=N2)C(CC)=C(C)\C2=C\C4=C(C=O)C(C)=C5\C=C/2[C@@H](C)[C@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C1=N\2 QXWRYZIMSXOOPY-SKHCYZARSA-M 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- 210000001612 chondrocyte Anatomy 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- NHADDZMCASKINP-HTRCEHHLSA-N decarboxydihydrocitrinin Natural products C1=C(O)C(C)=C2[C@H](C)[C@@H](C)OCC2=C1O NHADDZMCASKINP-HTRCEHHLSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000816 effect on animals Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000002803 fossil fuel Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000003869 genetically modified organism Nutrition 0.000 description 1
- 239000006481 glucose medium Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- -1 glutamine Chemical class 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 210000000777 hematopoietic system Anatomy 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229910003480 inorganic solid Inorganic materials 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229910052680 mordenite Inorganic materials 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229940028444 muse Drugs 0.000 description 1
- 229910052758 niobium Inorganic materials 0.000 description 1
- 239000010955 niobium Substances 0.000 description 1
- GUCVJGMIXFAOAE-UHFFFAOYSA-N niobium atom Chemical compound [Nb] GUCVJGMIXFAOAE-UHFFFAOYSA-N 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 210000001711 oxyntic cell Anatomy 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 210000001778 pluripotent stem cell Anatomy 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 210000005227 renal system Anatomy 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000011655 sodium selenate Substances 0.000 description 1
- 235000018716 sodium selenate Nutrition 0.000 description 1
- 229960001881 sodium selenate Drugs 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 125000001174 sulfone group Chemical group 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 239000012581 transferrin Substances 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000004065 wastewater treatment Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/12—Unicellular algae; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0025—Culture media for plant cell or plant tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/76—Undefined extracts from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
Definitions
- the present invention relates to a method for producing a composition for animal cell culture, a composition for animal cell culture obtained thereby, and a method for culturing animal cells using the same.
- Mammalian cells are used in various research and industrial fields such as medicine, pharmacology, science and technology, agriculture, and veterinary medicine. Studies using these cell culture techniques have elucidated various etiologies and led to the development of various treatments. Biopharmaceuticals, antibody drugs, and vaccines produced from mammalian cells are used for the treatment/prevention of various diseases. Furthermore, cultured cells have greatly contributed to the progress of basic academic fields such as cell biology, biochemistry, genetics, physiology, and molecular biology.
- cultured muscle cells have been utilized as a source of cells for "cultured meat.”
- the protein production efficiency of "cultured meat” is much more efficient than production by conventional livestock farming, and by changing meat production from conventional livestock farming to a cultured meat production system, land use can be reduced by up to 99%. , can reduce water consumption by 96%, greenhouse gas emissions by 96%, and energy consumption by 45%. Therefore, it is believed that meat production using cultured cells will spread worldwide as a sustainable food production system in the future. In the future, the use of cultured mammalian cells as food is expected to require enormous amounts of cells.
- Medium is essential for culturing mammalian cells, and even today large amounts of medium are used for cell research.
- the medium contains various nutrients, the main ones being glucose and amino acids. Those nutrients are derived from grains and heterotrophic microorganisms, and those heterotrophic microorganisms also require various nutrients derived from grains. Cultivation of cereals requires many chemical fertilizers and pesticides, consumes a huge amount of energy, and causes greenhouse gas (GHG) generation and environmental pollution. Grain production is greatly affected by environmental changes such as global warming and environmental pollution.
- Non-Patent Documents 1 to 3 wastewater treatment using the ability of microalgae to assimilate nitrogen, fixation of carbon dioxide gas generated from the combustion of fossil fuels, and the like.
- Microalgae synthesize nutrients such as carbohydrates (sugars) and lipids from carbon dioxide through photosynthesis, and produce amino acids using nitrogen gas/ammonia/nitrates. Microalgae efficiently produce various nutrients by using solar energy and minerals. Those nutrients produced by microalgae are utilized in various fields such as the energy and food industry fields. For example, lipids extracted from microalgae are expected as an alternative energy to petroleum (Non-Patent Document 4). Moreover, glucose extracted from microalgae is used as a nutrient for yeast that produces bioethanol (Non-Patent Documents 5-6).
- Microalgae are generally considered to be the most efficient photosynthetic organisms that synthesize nutrients with little residue (Non-Patent Document 11).
- a microalgae extract with a synthetic medium (e.g., mineral salt medium) that does not contain components such as amino acids (particularly glutamine, etc.) and vitamins that are essential for cell culture? is not described, much less that it can completely replace supplemental factors in serum or serum-free cultures.
- a synthetic medium e.g., mineral salt medium
- animal cells can be cultured in a medium (for example, a medium containing no amino acids and/or vitamins) supplemented with an algae extract obtained by hydrolyzing microalgae using a liquid acid (Patent Reference 4).
- a medium for example, a medium containing no amino acids and/or vitamins
- an algae extract obtained by hydrolyzing microalgae using a liquid acid (Patent Reference 4).
- Patent Reference 4 it is not described that the extract can completely replace the added factor of serum or serum-free culture.
- algae-derived amino acids for example, mycosporin-like amino acids (Patent Document 5)
- sulfated polysaccharides in particular, fucoidin (Patent Document 6)
- Patent Document 5 mycosporin-like amino acids
- Patent Document 6 sulfated polysaccharides
- Patent Documents 7 to 8 A technique using a solid acid as a hydrolysis catalyst for obtaining a saccharified solution containing monosaccharides from seaweed biomass and plant materials has been reported, but there is no disclosure about culturing cells using the obtained saccharified solution. (Patent Documents 7 to 8).
- the purpose of the present invention is to establish a new cell culture system that reduces the environmental load and the risk of environmental change.
- the inventors have conducted research and development by adding studies from various angles.
- a medium supplemented with nutrients extracted from microalgae using a solid acid catalyst can be used in animals It was found that cells can be cultured. That is, the present invention includes the following aspects.
- a method for producing a composition for animal cell culture Less than: (1) mixing algae with a solid acid catalyst and heating to obtain an algal extract; and (2) adding the algal extract to an animal cell culture medium to adjust the concentration of the algal extract to A method comprising the step of adjusting.
- the method according to item 1 wherein the animal cell culture medium does not substantially contain added factors for serum and/or serum-free culture.
- the method according to item 1 or 2 wherein the animal cell culture medium does not substantially contain glucose.
- the animal cell culture medium contains L-glutamine, L-arginine, L-cystine, glycine, L-histidine, L-isoleucine, L-leucine, L-lysine, L-methionine, L-phenylalanine, L -The method according to any one of items 1 to 3, wherein the method does not substantially contain one or more amino acids selected from the group consisting of serine, L-threonine, L-tryptophan, L-tyrosine, and L-valine. . [5] The method according to any one of items 1 to 4, wherein the animal cell culture medium does not substantially contain vitamins.
- the solid acid catalyst is obtained by introducing a sulfo group into a wood-based solid acid catalyst and sulfonating it, or by introducing a sulfo group into a phenolic resin and sulfonating it.
- composition for animal cell culture obtained by the method according to any one of items 1 to 11.
- a method for producing an algae extract for use in preparing a composition for animal cell culture comprising: (1) A process comprising mixing algae with a solid acid catalyst and heating to obtain an algal extract. [16] The method according to item 15, wherein the animal cell culture medium does not substantially contain serum and/or serum-free culture additive factors. [17] The method according to item 15 or 16, wherein the composition for animal cell culture does not substantially contain glucose.
- the animal cell culture composition contains L-glutamine, L-arginine, L-cystine, glycine, L-histidine, L-isoleucine, L-leucine, L-lysine, L-methionine, L-phenylalanine, L-serine, L-threonine, L-tryptophan, L-tyrosine, and L-valine according to any one of items 15-17 substantially free of amino acids selected from the group consisting of Method. [19] The method according to any one of items 15 to 18, wherein the composition for animal cell culture does not substantially contain vitamins. [20] The method according to any one of items 15 to 19, wherein the animal cell culture composition is an inorganic salt medium.
- the solid acid catalyst is obtained by introducing a sulfo group into a woody solid acid catalyst or a phenolic resin by introducing a sulfo group into a carbide derived from a woody raw material and sulfonating it.
- the method of the present invention it is possible to easily extract the nutrients necessary for cell culture from microalgae, and it is possible to provide a new cell culture system that is inexpensive and reduces the environmental burden.
- Relative viable cell numbers of primary bovine myoblasts cultured with DMEM with or without glucose/serum Relative viable cell numbers of primary bovine myoblasts cultured with DMEM with or without glucose/serum. Relative viable cell numbers of primary bovine myoblasts cultured in glucose/serum-free DMEM supplemented with algal extract obtained under each extraction condition. Relative viable cell numbers of primary bovine myoblasts cultured in glucose/serum-free DMEM supplemented with algal extract obtained under each extraction condition. Microscopic images of primary bovine myoblasts cultured in each medium. Microscopic images of primary bovine myoblasts cultured in each medium. Relative viable cell numbers of primary bovine myoblasts cultured in glucose/serum-free DMEM supplemented with algal extract obtained under each extraction condition. Animal muscle cell culture using solid acid-treated algae (Chlorococcum) extract (micrograph). Animal muscle cell culture (quantitative evaluation) using solid acid-treated algal (
- the present invention provides a method for producing a composition for animal cell culture, Less than: (1) mixing algae with a solid acid catalyst and heating to obtain an algal extract; and (2) substantially free of said algal extract and added factors of serum and/or serum-free culture.
- a method is provided comprising mixing an animal cell culture medium.
- the present invention also provides a method for producing a composition for animal cell culture, comprising: (1) mixing algae with a solid acid catalyst and heating to obtain an algal extract; and (2) adding the algal extract to an animal cell culture medium to adjust the concentration of the algal extract to A method is provided, comprising the step of adjusting.
- composition for animal cell culture containing algae-derived components (algae extract) obtained by the method of the present invention may contain substantially no added factors for serum and/or serum-free culture, It was completed through the surprising finding that it exhibits an effect equal to or greater than that of an animal cell medium supplemented with serum or serum-free culture additive factors required for maintenance and proliferation. Therefore, the composition for animal cell culture provided by the present invention does not require the addition of serum or serum-free culture additive factors used in conventional animal cell culture. Serum, in particular, has problems such as its quality varying from lot to lot and being expensive, but the present invention contributes to solving these problems.
- the concentration of the algae extract in the composition for animal cell culture is not limited because the conditions vary depending on the extraction conditions of the algae extract, the type or amount of algae used as a raw material, the type of animal cells to be cultured, and the like.
- the algal extract is 0.1 to 99% (v/v), 1 to 80% (v/v), 2 to 50% ( v/v), 3-30% (v/v), 5-25% (v/v).
- serum refers to the pale yellow liquid component that forms the supernatant when blood is coagulated, and contains growth factors and other factors necessary for cell proliferation. Its origin is not particularly limited and may be human, bovine fetus, bovine newborn, horse, chicken, rabbit, or the like. Even if the composition for animal cell culture provided by the present invention does not contain these sera, it is possible to grow animal cells to the same or greater extent than when sera are contained.
- the term "additive factor for serum-free culture” refers to a factor that is generally added in place of serum in a serum-free medium to proliferate (grow) cells, such as insulin, transferrin, ethanolamine, It refers to substances such as sodium selenate, albumin, mercaptoethanol, prostaglandin, etc., which are added to the serum-free medium in accordance with the cells of interest. Even if the composition for animal cell culture provided by the present invention does not contain these supplemental factors for serum-free culture, the composition for animal cell culture is equivalent to or more than the case where the additive factor for serum-free culture is contained. can be propagated.
- solid acid catalyst refers to a catalyst composed of an acid that is solid and dispersed in the reaction solution, such as zeolite, alumina, silica, H-mordenite, niobium Inorganic solid acids such as acids and organic materials such as resins such as strongly acidic ion exchangers (e.g., Amberlyst (trademark) -15, Nafion (trademark) NR-50, etc.) are added to sulfone groups, carboxyl groups, phenol A solid acid catalyst prepared in the form of powder or granules may be used in order to increase the contact surface area.
- strongly acidic ion exchangers e.g., Amberlyst (trademark) -15, Nafion (trademark) NR-50, etc.
- the neutralization treatment required when using a liquid acid becomes unnecessary. This suppresses an increase in salt concentration due to salt that may be caused by the neutralization treatment. Moreover, the solid acid catalyst can be recovered and reused, and it is possible to reduce the environmental load.
- a sulfo group is introduced into a woody solid acid catalyst or a phenolic resin obtained by introducing a sulfo group into a carbide derived from a woody raw material and sulfonating it.
- a resin solid acid catalyst or the like obtained by sulfonating a compound may be used.
- the woody solid acid catalyst that can be used in one embodiment of the present invention is carbonized under temperature conditions that do not burn off the woody raw material to form a carbide, and introduces a sulfo group (also referred to as a sulfonic acid group). It may be obtained by sulfonation.
- a sulfo group also referred to as a sulfonic acid group
- woody solid acid catalysts include those disclosed in Japanese Patent No. 5528036 and J. Am. Am. Chem. Soc 2008, vol. 130, No. 38, 12787-12793 can be used.
- the resin solid acid catalyst that can be used in one embodiment of the present invention may be obtained by introducing a sulfo group into a phenolic resin as a raw material and performing sulfonation.
- Animal cell culture media that can be used in the present invention include L-glutamine, L-arginine, L-cystine, glycine, L-histidine, L-isoleucine, L-leucine, L-lysine, L-methionine, and L-phenylalanine. , L-serine, L-threonine, L-tryptophan, L-tyrosine, and L-valine. Even if these amino acids contained in conventional animal cell culture media are deficient, the algal extract obtained by the present invention can substitute for these amino acids and allow animal cells to proliferate.
- the animal cell culture medium that can be used in the present invention can be an animal cell culture medium that does not substantially contain vitamins.
- Animal cell culture media that are substantially free of vitamins that can be used in the present invention include, for example, pantothenic acid, choline chloride, folic acid, i-inositol, niacinamide, pyridoxine, riboflavin, thiamine, and pharmaceuticals thereof. It may be substantially free of one or more vitamins selected from the group consisting of legally acceptable salts. Even if these vitamins contained in conventional animal cell culture media are deficient, the algae extract obtained by the present invention can substitute for these vitamins and allow animal cells to proliferate.
- the animal cell culture medium that can be used in the present invention may be an animal cell culture medium that does not substantially contain glucose, and an animal cell culture medium that does not substantially contain pyruvic acid. may be Even if conventional media for animal cell culture lack glucose, the algae extract obtained by the present invention can replace glucose and grow animal cells.
- substantially free means that the relevant substance is hardly contained, but does not mean that the relevant substance is not contained at all.
- it may contain less than the lower limit of quantification of 10 mg / L (eg, less than 10 mg / L, less than 5 mg / L, or less than 1 mg / L), for example, amino acids (eg, L-glutamine, etc.) If so, the content may be less than the lower limit of quantitative determination of 0.1 mg/L, or in the case of vitamins, the content may be less than the lower limit of quantitative determination of 1 ⁇ g/L.
- less than 1% (v/v) e.g., less than 1% (v/v), less than 0.5% (v/v), or less than 0.1% (v/v)
- it may be contained less than 1 ⁇ g/L (e.g., less than 1 ⁇ g/L, less than 0.5 ⁇ g/L, less than 0.1 ⁇ g/L) good too.
- algae is a general term for organisms that produce oxygen through photosynthesis, excluding bryophytes, fern plants, and seed plants that live mainly on the ground. If the environment necessary for photosynthesis is prepared, algae can produce oxygen and nutrients (for example, glucose and amino acids) by themselves and grow. The present invention was completed by discovering that cells can be cultured in a medium supplemented with a composition containing components extracted from algae.
- algae to which the present invention can be applied may be "microalgae (also referred to as "unicellular algae”).
- microalgae refers to algae, among algae, in which individuals consist of a single cell, and a plurality of microalgae individuals gather to form colonies.
- narrow-haline or broad-haline microalgae For example, green algae with chlorophyll a and b as main pigments in chloroplasts, unicellular cyanobacteria with chlorophyll d as main pigments, and unicellular red algae with chlorophyll a and phycobilin protein as main pigments.
- microalgae examples include: To give a more detailed example, in green algae, Chlamydomonas reinhardtii (Japanese name: Chlamydomonas) (freshwater) of the order Chlamydomonas order, and Dunaliella salina (Japanese name: Donaliella salina) of the order Donaliella ) (marine), Volvox carteri (Japanese name: Volvox) (freshwater), Chlorococcum littorale (marine), Chlorococcum littorale (marine), Hydrodictyon reticulatum) (Japanese name: Amimidoro) (produced in freshwater), Pediastrum duplex (Japanese name: Kunshoumo) (produced in freshwater), Scenedesmus dimorphus (Japanese name: Ikadamo) (produced in freshwater) ), Chlorella sp.
- Chlorella of the order Trebouxia algal order Chlorella (for example, Chlorella vulgaris (freshwater), Chlorella pyrenoidosa (freshwater), Chlorella ⁇ Elpsoidea (Chlorella ellipsoidea) (freshwater), Chlorella regularis (freshwater)), Euglena gracilis and Euglena proxima ( Japanese name: Midorimushi) (freshwater).
- Chlorella vulgaris freshwater
- Chlorella pyrenoidosa freshwater
- Chlorella ⁇ Elpsoidea Chlorella ellipsoidea
- Chlorella regularis freshwater
- Euglena gracilis Japanese name: Midorimushi
- Midorimushi freshwater
- the Cyanobacteria phylum Acaryochloris marina marine
- Spirulina subsalsa freshwater
- Arthrospira platensis freshwater
- algae to which the present invention can be applied may be freshwater or marine, and/or narrow- or broad-haline microalgae, but preferably marine and/or broad-haline microalgae.
- algae to which the present invention can be applied may be freshwater or marine, and/or narrow- or broad-haline microalgae, but preferably marine and/or broad-haline microalgae.
- Chlorococcum littorale, Synechococcus algae, etc. but not limited thereto.
- Algae used in the present invention may be natural algae or algae grown by a known culture method.
- biopolymers such as proteins and polysaccharides are heated (for example, about 60° C. to about 200° C., preferably about 80° C. to about 180° C., more preferably about 70° C. to about 150° C., even more preferably about 95° C. to about 135° C.) to produce oligomers and monomers (peptides and amino acids in proteins, oligosaccharides and monosaccharides in polysaccharides). Therefore, in the present invention, the heating step is carried out at about 60°C to about 200°C, preferably about 80°C to about 180°C, more preferably about 70°C to about 150°C, even more preferably about 95°C to about 135°C. may be implemented.
- the time of the heating step of the present invention can be adjusted depending on the type, amount, or concentration of algae used, or the pH, temperature, and other conditions of the reaction solution. It may be conducted from 1 hour to about 36 hours, from about 2 hours to about 24 hours, from about 2.5 hours to about 12 hours, from about 2.5 hours to about 7 hours.
- the term "about” refers to a numerical value within a range of ⁇ 10%, preferably ⁇ 5%, more preferably ⁇ 3%, and still more preferably ⁇ 1% of the numerical value attached to it. meant to be included.
- the algae used in step (1) may be subjected to drying treatment, such as freeze-drying, before being subjected to heat treatment.
- step (1) may be performed under pressure.
- under pressure refers to atmospheric pressure, that is, pressure conditions higher than 1 atmosphere, for example, 1.1 atmosphere or more, 1.5 atmosphere or more, 1.8 atmosphere or more, or 2 atmosphere or more may be implemented in For example, it may be 1.1 to 300 atmospheres, 1.5 to 200 atmospheres, 1.8 to 100 atmospheres, 2 to 50 atmospheres, such as 2 to 20 atmospheres.
- Pressurization conditions may be implemented by any device or method, and for example, pressurization conditions can be achieved by using an autoclave.
- the present invention provides a composition for animal cell culture obtained by the method described above.
- the present invention provides a method for culturing animal cells using the composition for animal cell culture obtained by the method described above.
- animal cells refer to cells of vertebrates (mammals (also referred to as “mammals”), birds, amphibians, reptiles or fish), or invertebrates (e.g., sea squirts, arthropods (crustaceans) (e.g., shrimp, crab, etc.), insects, etc.), echinoderms (e.g., sea urchin, sea cucumber, starfish, etc.), mollusks (e.g., shellfish, squid, octopus, etc.), etc.).
- vertebrates e.g., mammals (also referred to as “mammals”), birds, amphibians, reptiles or fish), or invertebrates (e.g., sea squirts, arthropods (crustaceans) (e.g., shrimp, crab, etc.), insects, etc.), echinoderms (e.g., sea urchin, sea cucumber, starfish, etc.), mol
- animal cells to which the present invention can be applied are vertebrate cells (e.g., human, monkey, bovine, whale, bear, deer, horse, pig, wild boar, sheep, rabbit, rat, mouse, hamster, goat, Mammals such as dogs or cats; Birds such as chickens, ducks, geese, quail, ducks and pheasants; Amphibians such as frogs, salamanders and newts; Reptiles such as crocodiles, lizards, snakes, turtles and soft-shelled turtles; , carp, shark, eel, and pufferfish), invertebrates (e.g., sea squirts, arthropods (crustaceans (e.g., shrimp, crab, etc.), insects, etc.), echinoderms (sea urchins, sea cucumbers, starfish, etc.), mollusks (e.g., shellfish,
- animal cells in living tissue is, for example, muscle system (e.g., myoblasts), skin system (e.g., fibroblasts, keratinocytes), liver system (e.g., hepatocytes), renal system (e.g., kidney cells (e.g., HEK293)), cardiac system (e.g., cardiomyocytes), digestive system (e.g., oral mucosal cells, intestinal epithelial cells, parietal cells), hematopoietic system (e.g., hematopoietic stem cells), reproductive tissue system (e.g., , ovarian cells (e.g., CHO cells), sperm cells, uterine epithelial cells), mucosal cells (e.g., epithelial cells), bone tissue systems (e.g., osteoblasts, chondrocytes), and the like. It may be derived from tissue.
- muscle system e.g., myoblasts
- skin system e.g
- the composition for animal cell culture that can be provided by the present invention may contain one or more algae-derived components, for example, two or more algae-derived components.
- it may contain a combination of an algae-derived component containing a large amount of glucose and an algae-derived component containing a large amount of protein-constituting amino acids.
- the composition for animal cell culture that can be provided by the present invention is obtained by an extraction method other than a solid acid catalyst, such as ultrasonication or a method using liquid acid (eg, International Publication No. 2021/066113). It may also contain an algae extract that has been harvested.
- the medium to which the composition containing algae-derived components is added may be appropriately selected depending on the type of cells to be cultured.
- liquid Eagle's medium, Dulbecco's modified Eagle's medium (DMEM), DMEM: F12 medium, Glasgow minimum essential medium, Grace's insect medium, Ham's medium, Iscove's modified Eagle's medium, RPMI-1640 medium, L-15 medium, McCoy's 5A medium, etc.
- DMEM Dulbecco's modified Eagle's medium
- F12 medium Glasgow minimum essential medium
- Grace's insect medium Ham's medium
- Iscove's modified Eagle's medium RPMI-1640 medium
- L-15 medium McCoy's 5A medium
- glucose, vitamins and/or proteinogenic amino acids e.g., L-glutamine, L-arginine, L-cystine, glycine, L-histidine, L-isoleucine, L-leucine, L-lysine, L-methionine, L -one or more amino acids selected from the group consisting of phenylalanine, L-serine, L-threonine, L-tryptophan, L-tyrosine, and L-valine
- the medium may be a liquid medium or a solid medium.
- algae extract obtained by the method of the present invention By adding the algae extract obtained by the method of the present invention to an animal cell culture medium, nutrients necessary for cell survival (e.g., growth factors, glucose, proteinogenic amino acids, vitamins, etc.) are supplied. , cell culture becomes possible.
- the proportion of algae extract added to the animal cell culture medium may be appropriately adjusted according to the type of cells to be cultured. and the algal extract is 0.1-99% (v/v), 1-80% (v/v), 2-50% (v/v), 3-30% (v/v), 5 ⁇ 25% (v/v) may be present.
- the present invention provides a method for producing an algal extract for use in preparing an animal cell culture composition substantially free of added factors for serum and/or serum-free culture, comprising: A method is provided comprising the step of obtaining an algal extract by mixing algae with a solid acid catalyst and heating.
- the present invention also provides a method for producing an algae extract for use in preparing a composition for animal cell culture, comprising: A method is provided comprising the step of obtaining an algal extract by mixing algae with a solid acid catalyst and heating.
- the scope of the present invention also includes a method for producing an algae extract, which is intended for use in preparing an animal cell culture composition substantially free of added factors for serum and/or serum-free culture. Therefore, the step of mixing the algae extract provided by the present invention with the animal cell culture medium may be performed by the same person who implements the present invention, or may be performed by a person who implements the present invention. may be performed by
- the algal extract provided by the present invention is provided as a separately packaged kit from an animal cell culture medium substantially free of added factors for serum and/or serum-free culture. can be anything.
- the present invention provides methods for recycling algae and animal cells. Such methods are: (i) a step of culturing algae using waste liquid (first waste liquid) after culturing animal cells; (ii) collecting the algae, mixing with a solid acid catalyst and heating to obtain an algal extract; (iii) a step of adding the algae extract to the waste liquid (second waste liquid) after the algae culture in (i) and adjusting the concentration of the algae extract to produce a composition for animal cell culture; and (iv) culturing animal cells using the composition for animal cell culture.
- the medium (waste liquid) after culturing animal cells which had to be discarded after being produced in large amounts in the animal cell culturing process in the field of regenerative medicine or biopharmaceuticals, or in the field of cultured foods, can be converted into algae.
- microalgae can be utilized for culturing.
- the medium (waste liquid) after culturing algae can be further used for culturing animal cells.
- the first waste liquid in this specification, for convenience, “waste liquid ", but it does not mean that it is actually discarded.
- the animal cell culture medium before culturing animal cells that can be applied to the present invention is not limited as long as it is known, but examples include Eagle's medium, Dulbecco's modified Eagle's medium (DMEM), and DMEM:F12.
- the method for culturing animal cells that supply the first waste liquid applicable to the present invention may follow a known culture method (e.g., 37° C., saturated steam, 5% CO 2 humidified atmosphere), and is not particularly limited. .
- step (ii) "the step of collecting the algae, mixing with a solid acid catalyst and heating to obtain an algae extract" is the above step (1) of the method for producing a composition for animal cell culture. ) applies.
- step (iii) above “the algae extract is added to the waste liquid after the algae culture in (i) (referred to as "second waste liquid”), the concentration of the algae extract is adjusted, and the animal cell culture is performed.
- the explanation of step (2) of the method for producing a composition for animal cell culture can be applied.
- the waste liquid (second waste liquid) after culturing algae in (i) can be applied.
- Animal cells can be cultured using the composition for animal cell culture prepared in this step. By carrying out these methods, recycling culture methods for algae and animal cells are established.
- step (i) may be further performed by culturing algae using the waste liquid after culturing animal cells in step (iv) as the first waste liquid in step (i). .
- steps (i) to (iv) may be repeated any number of times.
- Example 1 Materials and methods 1-1. Microalgae Culture In this study, the eukaryotic microalgae Chlorella vulgaris Beijerinck (hereinafter referred to as "chlorella”) (NIES-2170) (National Institute for Environmental Studies, Ibaraki) was used. C. vulgaris was cultured using a mixed medium containing Gumborg B5 medium (Fuji Film Wako Pure Chemical Industries, Osaka) and 0.1% Hyponex (Hyponex Japan, Tokyo).
- Cultivation was carried out using four 1 L screw cap medium bottles (AS ONE, Osaka Prefecture), 60 rpm on a quadruple low-speed stirrer (AS ONE), and 20 % CO gas concentration by a gas exchanger (Tokai Hit, Shizuoka Prefecture). The measurement was carried out at a flow rate of 50 mL/min, under light conditions (LC-LED 450 W, Taitec, Saitama Prefecture) for 24 hours, and at room temperature (25° C.).
- the microalgae were collected using a centrifuge (Sorvall Xpro Series Centrifuge, Thermo-Fischer Scientific, Massachusetts, USA) (1700 x g, 10 minutes), and centrifuged twice with pure water (1700 x g, 5 min) and collected in a 50 mL screw bottle (As One). After that, it was dried with a freeze dryer (FDU-1200, Tokyo Rika, Tokyo).
- a centrifuge Sorvall Xpro Series Centrifuge, Thermo-Fischer Scientific, Massachusetts, USA
- freeze-dried chlorella was adjusted to 50 g/L and heated with 1N HCl at 100°C for 24 hours using a heat block (Labnet International Inc., New Jersey, USA). After heat treatment, it was neutralized with sodium hydroxide. Solids were removed by filtration, and the filtrate was centrifuged at 1700 ⁇ g for 5 minutes, and the supernatant was used for cell culture experiments.
- freeze-dried chlorella was adjusted to 50 g/L and extracted using an ultrasonic cell disruptor (Bioruptor UCD-200TM, Cosmo Bio, Tokyo). The extraction was performed with a power of 20 kHz and a treatment time of 10 minutes. Solids were removed by filtration, and the filtrate was centrifuged at 1700 ⁇ g for 5 minutes, and the supernatant was used for cell culture experiments.
- Ultrasonic cell disruptor Bioruptor UCD-200TM, Cosmo Bio, Tokyo
- Bovine myoblasts were seeded in 96-well plates (AGC Techno Glass Co., Shizuoka, Japan) at a density of 30,000 cells/well in DMEM supplemented with 10% FBS and 1% P/S. Incubate overnight. After overnight culture, the medium was discarded and washed twice with phosphate buffered saline (PBS, Sigma-Aldrich). Cells were then cultured for 3 days using DMEM containing 10% FBS, DMEM without bovine serum, nutrient-deficient medium, and algae extract-supplemented nutrient-deficient medium.
- each solution was taken and 100 ⁇ L of 10% FBS and 1% P/S was added, followed by 50 ⁇ L of XTT reagent, just prior to performing the XTT assay. Subsequent cell viability assays were performed as per protocol.
- DMEM without glucose (Invitrogen) or mineral salt media containing only the mineral salt components of DMEM were self-made and used as nutrient-deficient media. Phase-contrast images of animal cells were acquired with a microscope (ELIPSE TS2, Nikon Corporation, Tokyo, Japan) using software (NIS-Elements BR, Nikon).
- the medium used in this example had the following composition unless otherwise specified.
- FBS media containing 10% FBS or no FBS were used.
- Carbohydrate Glucose 1000 mg/L or 4500 mg/L ⁇ Pyruvate: 110mg/L
- microalgae were hydrolyzed under the following conditions, and the resulting algae extract was used to produce bovine myoblasts. Cells were cultured for 3 days.
- the algae extract obtained by hydrolysis under extraction conditions 7 had the same degree of cell proliferation as the algae extract obtained under extraction conditions 1 (130°C, 3 hours). (Fig. 3).
- Example 2 Regarding algal extract concentrations, higher concentrations generally resulted in higher relative viable cell counts, as shown in FIGS. However, this may not always be the case, and this varied depending on the extraction conditions and the type of algae. Therefore, when constructing the recycling system described below, it is necessary to determine the concentration of the extract based on the extraction conditions and the component analysis of the medium so as to maximize the number of viable cells.
- Algae Chlorococcum ⁇ Addition of an extract from C2C12 mouse myoblasts revealed that animal cells (C2C12 mouse myoblasts) could be cultured (Fig. 7, A: micrograph after culture; B: relative viable cells quantitative evaluation of numbers). Therefore, algae are cultured using the waste liquid after animal cell culture, and the extract extracted by solid acid treatment of the algae is used as the waste liquid (second waste liquid) after culturing algae using the animal cell waste liquid (first waste liquid). ) and used to culture animal cells.
Landscapes
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
以下:
(1)藻類を固体酸触媒と混合し、加熱することによって、藻類抽出物を得る工程;及び
(2)前記藻類抽出物を、動物細胞培養用培地に添加し、前記藻類抽出物の濃度を調整する工程
を含む、方法。
[2]前記動物細胞培養用培地が、血清及び/又は無血清培養の添加因子を実質的に含まない、項目1に記載の方法。
[3] 前記動物細胞培養用培地が、グルコースを実質的に含まない、項目1又は2に記載の方法。
[4] 前記動物細胞培養用培地は、L-グルタミン、L-アルギニン、L-シスチン、グリシン、L-ヒスチジン、L-イソロイシン、L-ロイシン、L-リジン、L-メチオニン、L-フェニルアラニン、L-セリン、L-スレオニン、L-トリプトファン、L-チロシン、及びL-バリンからなる群から1又は複数選択されるアミノ酸を実質的に含まない、項目1~3のいずれか1項に記載の方法。
[5] 前記動物細胞培養用培地が、ビタミン類を実質的に含まない、項目1~4のいずれか1項に記載の方法。
[6] 前記動物細胞培養用培地が、無機塩培地である、項目1~5のいずれか1項に記載の方法。
[7] 前記藻類が、微細藻類である、項目1~6のいずれか1項に記載の方法。
[8] 前記藻類が、クロレラ属の微細藻類である、項目1~7のいずれか1項に記載の方法。
[9] 前記固体酸触媒が、木質系原料に由来する炭化物にスルホ基を導入してスルホ化することにより得た木質固体酸触媒又はフェノール樹脂にスルホ基を導入してスルホ化することにより得た樹脂固体酸触媒である、項目1~8のいずれか1項に記載の方法。
[10] 前記工程(1)が、70℃~150℃で実施される、項目1~9のいずれか1項に記載の方法。
[11] 前記工程(1)が、2時間~24時間実施される、項目1~10のいずれか1項に記載の方法。
(ii)前記藻類を回収し、固体酸触媒と混合して加熱することによって、藻類抽出物を得る工程;
(iii)前記藻類抽出物を、前記(i)の藻類培養後の廃液(第2廃液)に添加し、前記藻類抽出物の濃度を調整して動物細胞培養用組成物を製造する工程;及び
(iv)前記動物細胞培養用組成物を用いて動物細胞を培養する工程
を含む、藻類及び動物細胞のリサイクル培養方法。
(1)藻類を固体酸触媒と混合し、加熱することによって藻類抽出物を得る工程
を含む、方法。
[16] 前記動物細胞培養用培地が、血清及び/又は無血清培養の添加因子を実質的に含まない、項目15に記載の方法。
[17] 前記動物細胞培養用組成物が、グルコースを実質的に含まない、項目15又は16に記載の方法。
[18] 前記動物細胞培養用組成物は、L-グルタミン、L-アルギニン、L-シスチン、グリシン、L-ヒスチジン、L-イソロイシン、L-ロイシン、L-リジン、L-メチオニン、L-フェニルアラニン、L-セリン、L-スレオニン、L-トリプトファン、L-チロシン、及びL-バリンからなる群から1又は複数選択されるアミノ酸を実質的に含まない、項目15~17のいずれか1項に記載の方法。
[19] 前記動物細胞培養用組成物が、ビタミン類を実質的に含まない、項目15~18のいずれか1項に記載の方法。
[20] 前記動物細胞培養用組成物が、無機塩培地である、項目15~19のいずれか1項に記載の方法。
[21] 前記藻類が、微細藻類である、項目15~20のいずれか1項に記載の方法。
[22] 前記藻類が、クロレラ属の微細藻類である、項目15~21のいずれか1項に記載の方法。
[23] 前記固体酸触媒が、木質系原料に由来する炭化物にスルホ基を導入してスルホ化することにより得た木質固体酸触媒又はフェノール樹脂にスルホ基を導入してスルホ化することにより得た樹脂固体酸触媒である、項目15~22のいずれか1項に記載の方法。
[24] 前記工程(1)が、70℃~150℃で実施される、項目15~23のいずれか1項に記載の方法。
[25] 前記工程(1)が、2時間~24時間実施される、項目15~24のいずれか1項に記載の方法。
[26] 前記工程(1)が、加圧下において実施される、項目15~25のいずれか1項に記載の方法。
以下:
(1)藻類を固体酸触媒と混合し、加熱することによって、藻類抽出物を得る工程;及び
(2)前記藻類抽出物と、血清及び/又は無血清培養の添加因子を実質的に含まない動物細胞培養用培地を混合する工程
を含む、方法を提供する。
(1)藻類を固体酸触媒と混合し、加熱することによって、藻類抽出物を得る工程;及び
(2)前記藻類抽出物を、動物細胞培養用培地に添加し、前記藻類抽出物の濃度を調整する工程を含む、方法を提供する。
藻類を固体酸触媒と混合し、加熱することによって藻類抽出物を得る工程
を含む、方法を提供する。
藻類を固体酸触媒と混合し、加熱することによって藻類抽出物を得る工程
を含む、方法を提供する。
(i)動物細胞を培養した後の廃液(第1廃液)を使って藻類を培養する工程;
(ii)前記藻類を回収し、固体酸触媒と混合して加熱することによって、藻類抽出物を得る工程;
(iii)前記藻類抽出物を、前記(i)の藻類培養後の廃液(第2廃液)に添加し、前記藻類抽出物の濃度を調整して動物細胞培養用組成物を製造する工程;及び
(iv)前記動物細胞培養用組成物を用いて動物細胞を培養する工程
を含み得る。
1.材料と方法
1-1.微細藻類培養
本研究では、真核微細藻類クロレラ・ブルカリス・ベイエリンク(Chlorella vulgaris Beijerinck)(以下、「クロレラ」という。)(NIES-2170)(国立環境研究所、茨城県)を使用した。C.vulgarisはガンボーグB5培地(富士フィルム和光純薬、大阪府)と0.1%のハイポネックス(ハイポネックスジャパン、東京都)を混合した培地を利用して培養した。培養はそれぞれ1Lのネジ口メディウム瓶(アズワン、大阪府)を4本用いて、4連低速スターラー(アズワン)上で60rpm、ガス交換器(東海ヒット、静岡県)によるCO2ガス濃度20%ガス流量50mL/分、24時間光条件下(LC-LED 450W, タイテック、埼玉県)、室温(25℃)の環境下で行った。7日培養後、微細藻類を遠心機(Sorvall Xpro Series Centrifuge、Thermo-Fischer Scientific,マサチューセッツ州、米国)を用い(1700×g、10分)回収し、純水で2度遠心洗浄後(1700×g、5分)、50mLスクリュー瓶(アズワン)に回収した。その後、凍結乾燥機(FDU-1200, 東京理化、東京都)により乾燥させた。
微細藻類から栄養素を抽出するために加水分解法(以下、「固体酸処理」および「液体酸処理」という。)を用いた。上述した乾燥藻類の重量を秤量し、固体酸を用いた場合は表1に示す各条件で処理した。具体的には、凍結乾燥したクロレラ(100又は200mg)、固体酸(ZP150DH、フタムラ化学株式会社、愛知、日本)200mgを蒸留水(4mL)を加え、所定の温度で加熱撹拌した。反応後、固形物をろ過により取り除き、ろ液を1700×gで5分遠心処理後、その上清を細胞培養実験に用いた。
初代ウシ筋芽細胞は東京芝浦臓器株式会社から購入したウシ頬肉から単離した。初代ウシ筋芽細胞は10%ウシ胎仔血清(FBS、Thermo-Fischer Scientific,マサチューセッツ州、米国)と1%ペニシリン-ストレプトマイシン(P/S、Invitrogen、Carlsbad、カリフォルニア州、米国)が補充されたダルベッコ改良イーグル培地(DMEM)(Sigma-Aldrich,ミズーリ州、米国)により37℃で5%CO2を含む湿潤雰囲気下で培養した。相対生細胞数は、XTTアッセイ(Biological Industies,コネチカット州、米国)および細胞の顕微鏡観察により評価した。ウシ筋芽細胞を96ウェルプレート(AGCテクノグラス株式会社、静岡県、日本)中に30,000細胞/ウェルの密度で播種し、10%FBSと1%P/Sが補充されたDMEM中で一晩培養した。一晩培養後、培地を捨て、リン酸塩緩衝生理食塩水(PBS、Sigma-Aldrich社)で2回洗浄した。その後、10%FBS含有DMEM、ウシ血清不含DMEM、栄養欠損培地および栄養欠損培地に藻類抽出物添加したサンプルを用いて細胞を3日間培養した。各溶液中の色素による吸光度の差をなくすために、XTTアッセイを実施する直前に、各溶液を取り、100μLの10%FBSと1%P/Sを加え、次いで50μLのXTT試薬を添加した。それに続く細胞生死判別試験はプロトコル通り実施した。グルコース不含DMEM(Invitrogen)またはDMEMの無機塩成分のみを含む無機塩培地を自作し、栄養素欠損培地として使用した。また動物細胞の位相差画像は、顕微鏡(ELIPSE TS2、株式会社ニコン、東京都、日本)によりソフトウェア(NIS-Elements BR、ニコン)を使って取得した。
(A)通常の動物細胞培養に用いられる培地DMEMの栄養素・ミネラル組成
(i)糖質
・グルコース:1000mg/Lまたは4500mg/L
・ピルビン酸:110mg/L
(ii)アミノ酸
・L-アルギニン:84mg/L
・L-シスチン:48mg/L
・L-グルタミン:584mg/L
・グリシン:30mg/L
・L-ヒスチジン:42mg/L
・L-イソロイシン:105mg/L
・L-ロイシン:105mg/L
・L-リジン:146mg/L
・L-メチオニン:30mg/L
・L-フェニルアラニン:66mg/L
・L-セリン:42mg/L
・L-トレオニン:95mg/L
・L-トリプトファン:16mg/L
・L-チロシン:71mg/L
・L-バリン:94mg/L
(iii)ビタミン
・パントテン酸:4mg/L
・塩化コリン:4mg/L
・葉酸:4mg/L
・i-イノシトール:7.2mg/L
・ナイアシンアミド:4mg/L
・ピリドキシン:4mg/L
・リボフラビン:0.4mg/L
・チアミン:4mg/L
(iv)ミネラル
・CaCl2:200mg/L
・KCl:400mg/L
・Fe(NO3)3・9H2O:0.10mg/L
・MgSO4:98mg/L
・NaCl:6400mg/L
・NaHCO3:3700mg/L
・NaH2PO4:109mg/L
・フェノールレッド:15mg/L
(1)DMEM(グルコース不含)
藻類抽出液を用いることで糖質(グルコース・ピルビン酸)を代替可能であることを示すために用いた。
(i)糖質
・グルコース:0mg/L
・ピルビン酸:0mg/L
(ii)アミノ酸
・L-アルギニン:84mg/L
・L-シスチン:48mg/L
・L-グルタミン:584mg/L
・グリシン:30mg/L
・L-ヒスチジン:42mg/L
・L-イソロイシン:105mg/L
・L-ロイシン:105mg/L
・L-リジン:146mg/L
・L-メチオニン:30mg/L
・L-フェニルアラニン:66mg/L
・L-セリン:42mg/L
・L-トレオニン:95mg/L
・L-トリプトファン:16mg/L
・L-チロシン:71mg/L
・L-バリン:94mg/L
(iii)ビタミン
・パントテン酸:4mg/L
・塩化コリン:4mg/L
・葉酸:4mg/L
・i-イノシトール:7.2mg/L
・ナイアシンアミド:4mg/L
・ピリドキシン:4mg/L
・リボフラビン:0.4mg/L
・チアミン:4mg/L
(iv)ミネラル
・CaCl2:200mg/L
・KCl:400mg/L
・Fe(NO3)3・9H2O:0.10mg/L
・MgSO4:98mg/L
・NaCl:6400mg/L
・NaHCO3:3700mg/L
・NaH2PO4:109mg/L
・フェノールレッド:15mg/L
藻類抽出液を用いることで糖質(グルコース・ピルビン酸)、アミノ酸(L-アルギニン、L-シスチン、L-グルタミン、グリシン、L-ヒスチジン、L-イソロイシン、L-ロイシン、L-リジン、L-メチオニン、L-フェニルアラニン、L-セリン、L-トレオニン、L-トリプトファン、L-チロシン、L-バリン)およびビタミン(パントテン酸、塩化コリン、葉酸、i-イノシトール、ナイアシンアミド、ピリドキシン、リボフラビン、チアミン)を代替可能であることを示すために用いた。
(i)糖質
・グルコース:0mg/L
(ii)アミノ酸
・L-アルギニン:0mg/L
・L-シスチン:0mg/L
・L-グルタミン:0mg/L
・グリシン:0mg/L
・L-ヒスチジン:0mg/L
・L-イソロイシン:0mg/L
・L-ロイシン:0mg/L
・L-リジン:0mg/L
・L-メチオニン:0mg/L
・L-フェニルアラニン:0mg/L
・L-セリン:0mg/L
・L-トレオニン:0mg/L
・L-トリプトファン:0mg/L
・L-チロシン:0mg/L
・L-バリン:0mg/L
(iii)ビタミン
・パントテン酸:0mg/L
・塩化コリン:0mg/L
・葉酸:0mg/L
・i-イノシトール:0mg/L
・ナイアシンアミド:0mg/L
・ピリドキシン:0mg/L
・リボフラビン:0mg/L
・チアミン:0mg/L
(iv)ミネラル
・CaCl2:200mg/L
・KCl:400mg/L
・Fe(NO3)3・9H2O:0.10mg/L
・MgSO4:98mg/L
・NaCl:6400mg/L
・NaHCO3:3700mg/L
・NaH2PO4:109mg/L
・フェノールレッド:15mg/L
2-1.微細藻類抽出物を使った細胞培養
ウシ筋芽細胞培養の栄養素として藻類抽出物が利用可能かどうかを調べた。ウシ筋芽細胞を、グルコース及び/又は血清不含培地を使って培養した場合、3日後に栄養含有培地で培養した場合に比べ、いずれも細胞生存数の低下が認められた(図1)。しかしながら、固体酸を用い、C.vulgarisから抽出された抽出物を5%、10%及び20%添加することにより細胞生存率が回復し(図2)、さらに栄養含有培地を用い培養した場合よりも高い相対生細胞数を示した。この効果は抽出条件1(130℃、3時間)で最も高いものであった。この結果は、藻類抽出物が、哺乳類細胞の培養に、重要な栄養素であるグルコースおよびウシ血清の代用物として利用されることを証明した(図2)。
藻類抽出物の濃度について、図2、図3及び図6に示すように濃度が高い方が概して相対生細胞数が大きかった。しかし、必ずしもそうでない場合があり、これは抽出条件や藻類の種類によって異なっていた。従って、以下に記すリサイクルシステムを構築する場合、生細胞数が最大となるように抽出条件や培地の成分分析等に基づき抽出物の濃度を決定する必要がある。
Claims (15)
- 動物細胞培養用組成物を製造する方法であって、
以下:
(1)藻類を固体酸触媒と混合し、加熱することによって、藻類抽出物を得る工程;及び
(2)前記藻類抽出物を、動物細胞培養用培地に添加し、前記藻類抽出物の濃度を調整する工程
を含む、方法。 - 前記動物細胞培養用培地が、血清及び/又は無血清培養の添加因子を実質的に含まない、請求項1に記載の方法。
- 前記動物細胞培養用培地が、グルコースを実質的に含まない、請求項1又は2に記載の方法。
- 前記動物細胞培養用培地は、L-グルタミン、L-アルギニン、L-シスチン、グリシン、L-ヒスチジン、L-イソロイシン、L-ロイシン、L-リジン、L-メチオニン、L-フェニルアラニン、L-セリン、L-スレオニン、L-トリプトファン、L-チロシン、及びL-バリンからなる群から1又は複数選択されるアミノ酸を実質的に含まない、請求項1~3のいずれか1項に記載の方法。
- 前記動物細胞培養用培地が、ビタミン類を実質的に含まない、請求項1~4のいずれか1項に記載の方法。
- 前記動物細胞培養用培地が、無機塩培地である、請求項1~5のいずれか1項に記載の方法。
- 前記藻類が、微細藻類である、請求項1~6のいずれか1項に記載の方法。
- 前記藻類が、クロレラ属の微細藻類である、請求項1~7のいずれか1項に記載の方法。
- 前記固体酸触媒が、木質系原料に由来する炭化物にスルホ基を導入してスルホ化することにより得た木質固体酸触媒又はフェノール樹脂にスルホ基を導入してスルホ化することにより得た樹脂固体酸触媒である、請求項1~8のいずれか1項に記載の方法。
- 前記工程(1)が、70℃~150℃で実施される、請求項1~9のいずれか1項に記載の方法。
- 前記工程(1)が、2時間~24時間実施される、請求項1~10のいずれか1項に記載の方法。
- 請求項1~11のいずれか1項に記載の方法により得られる、動物細胞培養用組成物。
- 請求項1~11のいずれか1項に記載の方法により得られる動物細胞培養用組成物を用いる、動物細胞の培養方法。
- (i)動物細胞を培養した後の廃液(第1廃液)を使って藻類を培養する工程;
(ii)前記藻類を回収し、固体酸触媒と混合して加熱することによって、藻類抽出物を得る工程;
(iii)前記藻類抽出物を、前記(i)の藻類培養後の廃液(第2廃液)に添加し、前記藻類抽出物の濃度を調整して動物細胞培養用組成物を製造する工程;及び
(iv)前記動物細胞培養用組成物を用いて動物細胞を培養する工程
を含む、藻類及び動物細胞のリサイクル培養方法。 - 動物細胞培養用組成物の調製に用いるための藻類抽出物の製造方法であって、
(1)藻類を固体酸触媒と混合し、加熱することによって藻類抽出物を得る工程
を含む、方法。
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL309565A IL309565A (en) | 2021-06-23 | 2022-06-23 | A method for producing a preparation for propagating animal cells, a preparation for propagating animal cells obtained by said method, and a method for propagating animal cells using this preparation for propagating animal cells |
JP2023530127A JP7496175B2 (ja) | 2021-06-23 | 2022-06-23 | 動物細胞培養用組成物の製造方法、それにより得られる動物細胞培養用組成物及びそれを用いた動物細胞の培養方法 |
CN202280044679.7A CN117545836A (zh) | 2021-06-23 | 2022-06-23 | 动物细胞培养用组合物的制造方法、由此获得的动物细胞培养用组合物以及使用了该组合物的动物细胞的培养方法 |
EP22828514.4A EP4361254A1 (en) | 2021-06-23 | 2022-06-23 | Method for producing composition for culturing animal cells, composition for culturing animal cells obtained by said method, and method for culturing animal cells using said composition for culturing animal cells |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021-104448 | 2021-06-23 | ||
JP2021104448 | 2021-06-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022270598A1 true WO2022270598A1 (ja) | 2022-12-29 |
Family
ID=84544352
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2022/025179 WO2022270598A1 (ja) | 2021-06-23 | 2022-06-23 | 動物細胞培養用組成物の製造方法、それにより得られる動物細胞培養用組成物及びそれを用いた動物細胞の培養方法 |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP4361254A1 (ja) |
CN (1) | CN117545836A (ja) |
IL (1) | IL309565A (ja) |
WO (1) | WO2022270598A1 (ja) |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5765179A (en) | 1980-10-08 | 1982-04-20 | Dotsukiyou Gakuen | Cell culture |
JPS57206384A (en) | 1981-06-15 | 1982-12-17 | Kurorera Kogyo Kk | Cultivating method of cell |
JPS60186280A (ja) | 1984-03-07 | 1985-09-21 | 篠原 和毅 | 動物細胞生長促進組成物及びその製造方法 |
WO2000062785A1 (fr) | 1999-04-15 | 2000-10-26 | Takara Shuzo Co., Ltd. | Remedes |
JP2014036589A (ja) | 2012-08-13 | 2014-02-27 | Ihi Corp | 単糖の製造方法及び製造装置、エタノールの製造方法及び製造装置、並びに、フルフラール及びプラスチックの製造方法 |
JP5528036B2 (ja) | 2008-09-12 | 2014-06-25 | 公益財団法人神奈川科学技術アカデミー | 炭素系固体酸及びその製造方法 |
JP2016216750A (ja) | 2016-09-29 | 2016-12-22 | パナック株式会社 | 新規多糖体 |
JP2018516540A (ja) * | 2015-04-13 | 2018-06-28 | ビーエーエスエフ コーポレーション | バイオマスの発酵産物への変換 |
JP2019199462A (ja) | 2018-05-14 | 2019-11-21 | 国立大学法人東京工業大学 | マンノース抽出方法 |
WO2021066113A1 (ja) | 2019-10-01 | 2021-04-08 | 学校法人東京女子医科大学 | 細胞培養用組成物の製造方法、それにより得られる細胞培養用組成物及びそれを用いた細胞培養方法 |
-
2022
- 2022-06-23 WO PCT/JP2022/025179 patent/WO2022270598A1/ja active Application Filing
- 2022-06-23 IL IL309565A patent/IL309565A/en unknown
- 2022-06-23 EP EP22828514.4A patent/EP4361254A1/en active Pending
- 2022-06-23 CN CN202280044679.7A patent/CN117545836A/zh active Pending
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5765179A (en) | 1980-10-08 | 1982-04-20 | Dotsukiyou Gakuen | Cell culture |
JPS57206384A (en) | 1981-06-15 | 1982-12-17 | Kurorera Kogyo Kk | Cultivating method of cell |
JPS60186280A (ja) | 1984-03-07 | 1985-09-21 | 篠原 和毅 | 動物細胞生長促進組成物及びその製造方法 |
WO2000062785A1 (fr) | 1999-04-15 | 2000-10-26 | Takara Shuzo Co., Ltd. | Remedes |
JP5528036B2 (ja) | 2008-09-12 | 2014-06-25 | 公益財団法人神奈川科学技術アカデミー | 炭素系固体酸及びその製造方法 |
JP2014036589A (ja) | 2012-08-13 | 2014-02-27 | Ihi Corp | 単糖の製造方法及び製造装置、エタノールの製造方法及び製造装置、並びに、フルフラール及びプラスチックの製造方法 |
JP2018516540A (ja) * | 2015-04-13 | 2018-06-28 | ビーエーエスエフ コーポレーション | バイオマスの発酵産物への変換 |
JP2016216750A (ja) | 2016-09-29 | 2016-12-22 | パナック株式会社 | 新規多糖体 |
JP2019199462A (ja) | 2018-05-14 | 2019-11-21 | 国立大学法人東京工業大学 | マンノース抽出方法 |
WO2021066113A1 (ja) | 2019-10-01 | 2021-04-08 | 学校法人東京女子医科大学 | 細胞培養用組成物の製造方法、それにより得られる細胞培養用組成物及びそれを用いた細胞培養方法 |
Non-Patent Citations (18)
Title |
---|
A.K. SINGHM.P. SINGH: "Importance of algae as a potential source of biofuel", CELL MOL. BIOL. (NOISY-LE-GRAND, vol. 60, 2014, pages 106 - 109 |
ANONYMOUS: "Using Algae to Make Lab-Grown Meat Cheaper", NIKKEI SANGYO SHIMBUN, 7 May 2021 (2021-05-07), pages 7, XP009542856 * |
E.T. ALORIO.O. BABALOLA: "Microbial inoculants for improving crop quality and human health in Africa", FRONT. MICROBIOL, vol. 9, 2018, pages 2213 |
F. ROSSIE.J. OLGUINL. DIELSR. DE PHILIPPIS: "Microbial fixation of CO2 in water bodies and in drylands to combat climate change, soil loss and desertification", N. BIOTECHNOL, vol. 32, 2015, pages 109 - 120 |
G. GUTIERREZ-SALMEANL. FABILA-CASTILLOG. CHAMORRO-CEVALLOS: "Nutritional and toxicological aspects of Spirulina (Arthrospira", NUTR. HOSP, vol. 32, 2015, pages 34 - 40 |
G.E. LAKATOSK. RANGLOVAJ. C. MANOELT. GRIVALSKYJ. KOPECKY ET AL.: "Bioethanol production from microalgae polysaccharides", FOLIA MICROBIOL. (PRAHA, 2019 |
HARAGUCHI YSHIMIZU T: "Microalgal culture in animal cell waste medium for sustainable 'cultured food' production", ARCH. MICROBIOL, vol. 203, no. 9, November 2021 (2021-11-01), pages 5525 - 5532, XP037585213, DOI: 10.1007/s00203-021-02509-x |
HARAGUCHI YUJI; SHIMIZU TATSUYA: "Microalgal culture in animal cell waste medium for sustainable ‘cultured food’ production", ARCHIVES OF MICROBIOLOGY, SPRINGER BERLIN HEIDELBERG, BERLIN/HEIDELBERG, vol. 203, no. 9, 23 August 2021 (2021-08-23), Berlin/Heidelberg, pages 5525 - 5532, XP037585213, ISSN: 0302-8933, DOI: 10.1007/s00203-021-02509-x * |
I. AJJAWIJ. VERRUTOM. AQUIL.B. SORIAGAJ. COPPERSMITH ET AL.: "Lipid production in Nannochloropsis gaditana is doubled by decreasing expression of a single transcriptional regulator", NAT. BIOTECHNOL., vol. 35, 2017, pages 647 - 652, XP055540971, DOI: 10.1038/nbt.3865 |
J. AM. CHEM. SOC, vol. 130, no. 38, 2008, pages 12787 - 12793 |
J. CHENGY ZHUZ. ZHANGW. YANG: "Modification and improvement of microalgae strains for strengthening CO2 fixation from coal-fired flue gas in power plants", BIORESOUR. TECHNOL, 2019 |
L. WANGM. MINY. LIP. CHENY. CHEN ET AL.: "Cultivation of green algae Chlorella sp. in different wastewaters from municipal wastewater treatment plant", APPL. BIOCHEM. BIOTECHNOL., vol. 162, 2010, pages 1174 - 1186 |
M.I. KHANJ. H. SHINJ. D. KIM: "The promising future of microalgae: current status, challenges and optimization of a sustainable and renewable industry for biofuels, feed and other products", MICROB. CELL FACT, vol. 17, 2018, pages 36 |
OKAMOTO YUTA, HARAGUCHI YUJI, SAWAMURA NAOYA, ASAHI TORU, SHIMIZU TATSUYA: "Mammalian cell cultivation using nutrients extracted from microalgae", BIOTECHNOLOGY PROGRESS, AMERICAN CHEMICAL SOCIETY, vol. 36, no. 2, 1 March 2020 (2020-03-01), pages 1 - 9, XP093007555, ISSN: 8756-7938, DOI: 10.1002/btpr.2941 * |
OKAMOTO, YUTA ET AL.: "PB21 Animal Cell Culture Using Microalgae Extract for Meat Production", THE 44TH ANNUAL MEETING OF THE JAPANESE SOCIETY OF PHYCOLOGY - KAGOSHIMA 2020, 2020, pages 68 * |
S. MCCUSKERP.R. BUFFZ. YUA.J FASCETTI: "Amino acid content of selected plant, algae and insect species: a search for alternative protein sources for use in pet foods", J. NUTR. SCI, vol. 3, 2014, pages 39 |
S.H. HOS.W. HUANGC.Y CHENT. HASUNUMAA. KONDO ET AL.: "Bioethanol production using carbohydrate-rich microalgae biomass as feedstock", BIORESOUR. TECHNOL, vol. 135, 2013, pages 191 - 198, XP028579618, DOI: 10.1016/j.biortech.2012.10.015 |
SHIMIZU TATSUYA: "Bio-economical food production system using circular cell culture of algae and animal cells [FS]", 25 May 2021 (2021-05-25), XP093017408, Retrieved from the Internet <URL:https://www.naro.go.jp/laboratory/brain/moon_shot/MS_PM_E03.pdf> [retrieved on 20230125] * |
Also Published As
Publication number | Publication date |
---|---|
EP4361254A1 (en) | 2024-05-01 |
IL309565A (en) | 2024-02-01 |
CN117545836A (zh) | 2024-02-09 |
JPWO2022270598A1 (ja) | 2022-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7248349B2 (ja) | 細胞培養用組成物の製造方法、それにより得られる細胞培養用組成物及びそれを用いた細胞培養方法 | |
Chaiklahan et al. | Cultivation of Spirulina platensis using pig wastewater in a semi-continuous process | |
Deamici et al. | Static magnetic fields in culture of Chlorella fusca: Bioeffects on growth and biomass composition | |
JP2017077186A (ja) | プランクトンの異常増殖に対する水生生物の耐性改善方法 | |
Jia et al. | A preliminary study of the algicidal mechanism of bioactive metabolites of Brevibacillus laterosporus on Oscillatoria in prawn ponds | |
JP7288725B2 (ja) | 藻類を培養するための組成物および藻類の培養方法 | |
Pleissner et al. | Heterotrophic growth of Galdieria sulphuraria on residues from aquaculture and fish processing industries | |
Kumar et al. | Screening and evaluation of novel microalga Desmodesmus pannonicus CT01 for CO2 sequestration potential and aqua feed application | |
Thirumala | Optimization of growth of Spirulina platensis LN1 for production of carotenoids | |
WO2022270598A1 (ja) | 動物細胞培養用組成物の製造方法、それにより得られる動物細胞培養用組成物及びそれを用いた動物細胞の培養方法 | |
JP7496175B2 (ja) | 動物細胞培養用組成物の製造方法、それにより得られる動物細胞培養用組成物及びそれを用いた動物細胞の培養方法 | |
Prakash et al. | Effect of humic acid on Spirulina plantisis production and analysis of nutrient contents | |
Fathi et al. | Investigating the impact of NaCl salinity on growth, β-carotene, and chlorophyll a in the content life of halophytes of algae Chlorella sp. | |
Fakhri et al. | Biomass, pigment production, and nutrient uptake of Chlorella sp. under different photoperiods | |
KR101323957B1 (ko) | 저온에서 성장 가능한 신균주 클로렐라 불가리스 및 이의 용도 | |
RU2613424C1 (ru) | ПЛАНКТОННЫЙ ШТАММ Chlorella kessleri, ПРЕДНАЗНАЧЕННЫЙ ДЛЯ ПОЛУЧЕНИЯ БИОМАССЫ | |
Saranraj et al. | Effective recycling of lignite fly ash for the laboratory cultivation of blue green algae-Spirulina platensis | |
KR101323887B1 (ko) | 고온에서 성장 가능한 나노클로리스 속 신균주 및 이의 용도 | |
KR101323873B1 (ko) | 성장률이 우수한 나노클로롭시스 속 신균주 및 이의 용도 | |
Al-Adali et al. | Effect of salinity, temperature, nutrients and CO2 on growth of two species of microalgae from Red Sea, Saudi Arabia | |
NL2018539B1 (en) | Method for the production of microalgae | |
Murugan et al. | Growth and bio-pigment production of three microalgal species in organic and inorganic media and determination of generation time–a comparative study | |
Rahman et al. | Utilization of anaerobically digested dairy manure wastewater for Spirulina maxima cultivation | |
KR101322973B1 (ko) | 로도박터 스페로이드의 변이균주 추출물을 포함하는 성장촉진용 배지조성물 및 그 제조방법 | |
KR102603612B1 (ko) | 아스타잔틴 및 루테인 생산능을 가지는 클라미도모나스속 kiost-2 균주 및 이의 배양방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22828514 Country of ref document: EP Kind code of ref document: A1 |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2023530127 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 309565 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 18573148 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 202280044679.7 Country of ref document: CN |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112023026866 Country of ref document: BR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2022828514 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2022828514 Country of ref document: EP Effective date: 20240123 |
|
ENP | Entry into the national phase |
Ref document number: 112023026866 Country of ref document: BR Kind code of ref document: A2 Effective date: 20231219 |